scorecardresearch
Saturday, September 20, 2025
Topic2-DG

Topic: 2-DG

Mankind Pharma receives DRDO license to manufacture, market Covid drug 2-DG

Drugs Controller General of India (DCGI) had permitted the emergency use of 2-DG on 1 May, as an adjunct treatment for moderate to severe Covid-19 patients.

Dr Reddy’s announces commercial launch of Covid drug 2-DG, to cost Rs 990/sachet

The drug was developed by DRDO in collaboration with Dr Reddy's and granted emergency use approval on 1 May. It will be supplied to major govt and private hospitals across India.

On Camera

Was India’s public sector born out of European envy?

For all its obvious blemishes, capitalism alone holds out the most creative and dynamic force that any civilization has ever discovered, wrote BP Godrej in 1980.

Market regulator SEBI clears Adani Group of impropriety alleged by Hindenburg Research

SEBI probe concluded that purported loans and fund transfers were paid back in full and did not amount to deceptive market practices or unreported related party transactions.

2 Assam Rifles personnel killed as convoy ambushed in Manipur, on ‘same route Modi took’ fortnight ago

This is the first major attack on central security forces since last November, when a CRPF jawan was killed and four were injured in an ambush in Jiribam on Manipur-Assam border. 

India doesn’t give walkovers to Pakistan in war. Here’s why it shouldn’t do it in cricket either

Many really smart people now share the position that playing cricket with Pakistan is politically, strategically and morally wrong. It is just a poor appreciation of competitive sport.